Cognitive-behavioral treatment of body dysmorphic disorder.
2006, 13(7): 70-76.
Similarities and differences between body dysmorphic disorder and other disorders.
Hadley SJ, Kaplan A, Simeon D, Friedberg J, Priday L, Baker BR, Greenberg JL, Hollander E.
An open-label trial of venlafaxine in body dysmorphic disorder.
Beauty is in the eye of the beholder: New insights in imagined Ugliness.
Guest Editors' Note. Primary Psychiatry,
2006, 13(7): 70-76.
Allen A. Body Dysmorphic Disorder: Imagined Ugliness. Presentation at Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico of Milano, Italy, April 7, 2008.
Allen A. Workshop: Cognitive Behavioral Treatment for Body Dysmorphic Disorder. Presentation at the 2nd Annual Body Dysmorphic Disorder Conference, Hofstra University, Garden City, New York, October 22, 2006.
Allen A, Hollander E. Psychopharmacological treatment of body image disorders. In T Cash and T Pruzinski Eds. Body Image: A Handbook of Theory, Research, and Clinical Practice. New York, Guilford Press, 2004, pp.450-457.
Allen A, Hadley SJ, Kaplan A, Simeon D, Friedberg J, Priday L, Greenberg J, Hollander E. An open label trial of venlafaxine in body dysmorphic disorder. The 6th International Obsessive-Compulsive Disorder Conference, November 14, 2003, Lanzarote, Spain.
Allen A. Body Dysmorphic Disorder: Imagined Ugliness. Workshop at Image, Body & Self Conference, Hofstra University, April 8, 2003.
Allen A, Hollander E, & Buchsbaum M. Imaging in Body Dysmorphic Disorder. The 4th International Obsessive-Compulsive Disorder Conference, St Thomas, US Virgin Islands, February 11, 2000.
Allen A & Hollander E. Body Dysmorphic Disorder. Psychiatric Clinics of North America, 2000, 23:617-628.
Allen A. Body Dysmorphic Disorder. Anxiety Spectrum Disorders: New Concepts and Effective Treatments Symposium at the Mt. Sinai School of Medicine, New York, New York, November 4, 2000.
Hollander E, Allen A, Kwon J, Aronowitz BR, Schmeidler J, Wong C, Simeon S. Clomipramine vs. desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Archives of General Psychiatry, 1999. 56:1033-1039.
Allen A, Kaplan A. Workshop: Cognitive, Behavioral & Medication Therapies of Body Dysmorphic Disorder. Obsessive Compulsive Spectrum Disorders Conference, Mt. Sinai School of Medicine, New York, New York. April 1999.
Hollander E, Allen A, Schmeidler J, Kwon J, Aronowitz B, DeCaria C. Clomipramine vs. desipramine in body dysmorphic disorder: double blind crossover trial. Scientific Abstracts of the 37th Annual Meeting of the American College of Neuropsychopharmacology, 1998, Pg. 137.
Aronowitz BR, Simeon D, Margolin L, Silver L, Cooper B, Margolies S, Swiller H, Schmeidler J, Allen A, Persaud A, Greer J, Hollander E. A survey of body dysmorphic disorder in plastic surgery outpatients. Abstracts for the Mount Sinai Medical Center, Psychiatry Department, Annual Research Day, 1997.
Copyright © 2010-2011, Until Midnight. All rights reserved.